Difference between revisions of "Team:SDU-Denmark/Tour61"
Jpettersen (Talk | contribs) |
Jpettersen (Talk | contribs) |
||
| Line 14: | Line 14: | ||
When asked the question "Would you prefer if antibodies (or an antibody alternative) was produced in bacteria, such as E. coli?" 71,8% said "yes", 3,1% "no" and 25,2% aswered "don't care". | When asked the question "Would you prefer if antibodies (or an antibody alternative) was produced in bacteria, such as E. coli?" 71,8% said "yes", 3,1% "no" and 25,2% aswered "don't care". | ||
<br> | <br> | ||
| − | <img align="center" src="https://static.igem.org/mediawiki/2015/f/f9/SurveyPart1_SDU-Denmark.png" width=" | + | <img align="center" src="https://static.igem.org/mediawiki/2015/f/f9/SurveyPart1_SDU-Denmark.png" width="820px" /> |
<br> | <br> | ||
<br> | <br> | ||
Revision as of 17:49, 13 September 2015
Are peptide aptamers the new black?
We created a questionnaire designed to generate an idea of how much people generally know about antibodies, peptide aptamers and their opinions about usage of laboratory animals.
Responses
260 people endowed, representing five continents; Europe, North America, South America, Asia and Australia or the Ocenian Region.
Results
When asked the question "Would you prefer if antibodies (or an antibody alternative) was produced in bacteria, such as E. coli?" 71,8% said "yes", 3,1% "no" and 25,2% aswered "don't care".
Conclusion